- info@bpendo.org
- (405)-974-0776
BPEndo is proud to announce we recently closed a $3M Series A round for scaling manufacturing and commercialization. Our hope is to launch product in Q1 2025
BPEndo’s, Insufflation Retention Device (IRD) is an add-on device intended to make colonoscopies safer and more efficient. It solves the problem of air or fluid incontinence by creating a seal in the rectum while simultaneously allow full freedom of movement for the endoscope to ensure full visualization.
All components are made from previously FDA cleared devices.
Patents: US 10,918,815 B2 | US 11,273,269 B2 | FDA 510(k) cleared
The IRD was designed to be attached to any scope quickly so that the Endoscopist doesn’t lose any time.
Predicate Devices: Barium Enema & Fecal Management System.
The device fits any size scope and is inserted into the rectum.
The device is then inflated with a syringe to seal the rectum.
In under 30 seconds the colon is insufflated and free of air or fluid incontinence.
Save at least $15,000 in staffing costs, as well as costs to the patient and 3rd party payor
Minimally invasive and allows a physician to spot potential problems with greater accuracy.
The IRD gives physicians all of the visualization they need to perform a thorough exam
The IRD can be attached and inserted in less than a minute
Creative solution to a common problem faced by Gastroenterologists
The IRD is a simple, reliable device
Got questions? We’ve got answers. If you have some other questions, feel free to send us an email.
EG-Gilero is doing everything from the design to the manufacturing of the device. EG-Gilero has over 100 issued patents related to medical devices. Some of the biggest names in healthcare trust EG-Gilero such as: Johnson & Johnson, Medtronic, Bayer, Cardinal Health, BD, & Pfizer.
EG-Gilero has in house FDA regulatory experts that are navigated BPEndo through the FDA 510(k) clearance process. BPEndo took every step necessary to ensure that the IRD is compliant with all FDA regulations, and has secured approval.
The IRD is the only medical device of its kind. The device is compatible with any scope and is easily applied in less than a minute. The simplicity of the device allows for reduced costs and saved time for physicians, staff, and payors. The IRD is FDA approved.
BPEndo created the Insufflation Retention Device to solve the problem of air or fluid incontinence. Founder Dr. Holbrook has encountered this problem in his own practice, as well as other physicians and decided that there needed to be a device to address this unmet need in the market. The IRD will make colonoscopies simpler and more efficient for physicians, which will result in reduced costs and safer patient outcomes.